KIMBERLY CHARLTON: Open Payments
NPI 1447317771 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$756 in 8 payments from 5 companies in 2025. Trend: 2023 $931 · 2024 $298 · 2025 $756
Food & beverage: $756
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $234 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $166 |
| ABBVIE INC. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
| Alkermes, Inc. | 2 | $108 |
Products named: COBENFY, CAPLYTA, VRAYLAR, ABILIFY MAINTENA, LYBALVI, ARISTADA.
Industry payments across CA — which companies pay providers there.
